Mark Jones's reply to Myles and Leonardi-Bee's response to his critique of their paper reported in the BMJ

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Jones, Mark ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE INHIBITOR; ANTIVIRUS AGENT; ENZYME INHIBITOR; OSELTAMIVIR; SIALIDASE; ZANAMIVIR;

DRUG EFFECT; DRUG EXPOSURE; FOLLOW UP; HUMAN; IMMORTAL TIME BIAS; LETTER; MORTALITY; PRIORITY JOURNAL; STATISTICAL BIAS; SURVIVAL TIME; TIME; ANTAGONISTS AND INHIBITORS; FEMALE; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MALE; PANDEMIC;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; ZANAMIVIR;

EID: 84899656158     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3001     Document Type: Letter

References (4)

1. Myles PR, Leonardi-Bee J. Authors' reply to Mark Jones's critique of the study by Muthuri and colleagues reported in The BMJ. BMJ 2014;348:g2990.
2. Kmietowicz Z. Study claiming Tamiflu saved lives was based on "flawed" analysis. BMJ 2014;348:g2228. (19 March.)
3. Van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 2004;57:672-82.
4. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008;61:1216-21.